Some of the MSO’s didn’t fair nearly as bad as Canadian MJ.
Are we seeing a shift? I know Canopy is an exception as they can rock and roll in the US soon as legalization passes on a federal level. Many probably don’t realize that.
One other reason I can see an interest in MSO’s is many actually produce a profit already and their sales rival Canopy’s.
Klein is doing a better job cutting expenses, but sheesh without management getting rich at shareholder expense we would be about a $Billion closer, (OR MORE) to the green after all these quarters with massive payouts.
Share-based compensation expense in the nine months ended December 31, 2020 was $66.8 million, as compared to $217.6 million in the nine months ended December 31, 2019.
How can this company EVER produce a profit when share based compensation is sucking company dry?
Never seen anything like this except in the OTC pinkie world.
In18 months almost 300 HUNDRED MILLION $DOLLARS$ paid in stock based compensation.
Entire years revenue in 2020 was less than 400M
When do shareholders just say “Screw This” and move over to MSO’s who are already making a profit instead of feeding the machine.
Maybe it wouldn’t be so bad if Canopy actually had a PR department that kept investors informed instead of biting nails for three months waiting on some rid bit of info?
News 
Market Data 
Discover 
